To meet the high demand for novel and small carboxylic acid fragments for FBDD, we have carefully selected and created a library of 1807 soluble carboxylic acid fragments.
In overall, carboxylic acid fragment molecules have great potential for drug discovery of novel and difficult targets, such as protein-protein interactions, due to binding affinity to so-called “hot-spot” residues.
Solubility is one of the fundamental physicochemical properties of drug candidates, and early assessment of solubility properties can better interpret in vitro results and provide valuable information for the design of new molecules. Compounds with low solubility often produce erroneous results during functional assays, thus increasing the risk of obtaining false hits or leads. Measuring solubility at an early stage of the drug discovery process can identify potentially ambiguous activity data, such as false negatives due to poor solubility. The high solubility and good theoretical membrane permeability of soluble carboxylic acid fragment molecules can better address the limiting factors in drug discovery. Features:
Empty | 1000025-07-9 | 1000413-72-8 | 229005-80-5 | 1000787-75-6 | 946387-07-1 | 1000998-59-3 | 1175526-27-8 | 1001288-58-9 | 1001350-96-4 | 1001404-83-6 | Empty |
Vadadustat | TAK875 | TAK-779 | Tegobuvir | RN-1734 | BMS-687453 | AM211 | FT011 | BMS754807 | AAI101 | ||
Empty | 1001625-82-6 | 1001645-58-4 | 1001753-24-7 | 1001908-89-9 | 1002304-34-8 | 1002-84-2 | 100291-86-9 | 100299-08-9 | 10030-52-1 | 10040-45-6 | Empty |
RPW-24 | SRT1720 hydrochloride | INH6 | SRT 2183 | AMG208 | Pentadecanoic acid | Apiopaeonoside | Pemirolast potassium | L-Anserine nitrate salt | Sodium Picosulfate | ||
Empty | 100427-26-7 | 1004316-88-4 | 10045-45-1 | 100462-37-1 | 1004990-28-6 | 100-51-6 | 1005-24-9 | 1005264-47-0 | 1005334-57-5 | 1005342-46-0 | Empty |
Lercanidipine | Cobicistat | 1-Ethyl-2-benzimidazolinone | ROSIRIDIN | PF-AKT400 | Benzyl alcohol | 1-Methylnicotinamide chloride | MX69 | CVT-10216 | LCL161 | ||
Empty | 1005491-05-3 | 100-55-0 | 1005504-62-0 | 1005883-72-6 | 100643-71-8 | 1007207-67-1 | 10075-50-0 | 1007647-73-5 | 100784-20-1 | 10083-24-6 | Empty |
Tirasemtiv | Roniacol | Rg3039 | Z433927330 | Desloratadine | CH5132799 | 5-Bromoindole | Smurf1-IN-A01 | Halosulfuron-methyl | Piceatannol | ||
Empty | 100872-83-1 | 100874-08-6 | 1009119-64-5 | 1009119-65-6 | 100929-71-3 | 1009298-09-2 | 1009298-59-2 | 100929-99-5 | 1009734-33-1 | 10097-84-4 | Empty |
ML346 | SB 4 | Daclatasvir | Daclatasvir dihydrochloride | NADPH (tetracyclohexanamine) | AZD8055 | Vistusertib | PAβN dihydrochloride | HZ1157 | Rotundine | ||
Empty | 1009816-48-1 | 1009817-63-3 | 1009820-21-6 | 100986-85-4 | 101001-34-7 | 1010411-21-8 | 1010-60-2 | 1011244-68-0 | 1011301-27-1 | 1011529-10-4 | Empty |
Thiamet G | B-AP15 | Silmitasertib | Levofloxacin | Pamicogrel | GSK369796 Dihydrochloride | 2-Chloronaphthoquinone | TFAP | Tenovin3 | Azvudine | ||
Empty | 101152-94-7 | 101155-02-6 | 1011557-82-6 | 1011-74-1 | 101-20-2 | 1012054-59-9 | 101-21-3 | 101-26-8 | 101303-98-4 | 1013101-36-4 | Empty |
Milnacipran hydrochloride | BW-A78U | Tenovin-6 | DL-Normetanephrine hydrochloride | Triclocarban | CUDC101 | Chlorpropham | Mestinon | Zacopride hydrochloride | PF04691502 | ||
Empty | 101-31-5 | 1013-69-0 | 1013750-77-0 | 1013753-99-5 | 10138-52-0 | 1013920-15-4 | 1013937-63-7 | 1014691-61-2 | 101477-54-7 | 101494-95-5 | Empty |
L-Hyoscyamine | Noreugenin | ML-030 | BC-1382 | Gadolinium chloride | Vorolanib | VTP-27999 TFA | GSK0660 | Lomerizine hydrochloride | 8-CHLOROQUINAZOLIN-4(1H)-ONE |